What is CAR-T Cell Immunotherapy?
CAR-T is a personalized immunotherapy made from a patient’s white blood cells. The blood cells are removed from the patient and then modified with chimeric...
Read MoreNew Research Presented at San Antonio
The San Antonio Breast Cancer Symposium is a key breast cancer conference that takes place each year. Researchers often use this meeting to report results from...
Read MorePatient and Advocate Perspectives on San Antonio
Hundreds of breast cancer advocates attended the San Antonio Breast Cancer Symposium. Below you can listen to their podcasts and read about how they’ve...
Read MoreSupport for MBC Caregivers
Caregivers play a unique role in the lives of women and men with metastatic breast cancer. In this issue of MTT, we provide tips and resources to help caregivers...
Read MoreManaging Lymphedema
Lymphedema–swelling of the arm, hand, breast, or torso–is a side effect that can develop after breast surgery or radiation that can affect the quality...
Read MoreReporting Side Effects in Cancer Clinical Trials
More attention is now being paid to what types of side effects are reported in cancer clinical trials and how data on these side effects are collected....
Read MoreStories of De Novo Metastatic Breast Cancer
About 6-10% of breast cancer patients are initially diagnosed at stage IV. This is often called “de novo” – from the beginning metastatic...
Read MoreEvidence-Based Information on Herbs and Supplements
Herbs and supplements are widely advertised as beneficial to cancer patients. But how do you know which ones are safe? Memorial Sloan Kettering Cancer Center:...
Read MoreYour Tumor and Experience Could Lead to New Treatments
Metastatic breast cancer patients, advocates, and researchers have been working together to develop registries and databases where patients can share information...
Read MoreSEARCH OUR SITE
for past articles or specific information.